MariƱo, Liwayway C.
HRN: 26-88-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/08/2025
CEFUROXIME 1.5GM (VIAL)
04/08/2025
04/09/2025
IV
1.5
Q8
S/PCS With BTL
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes